Industry Group: Pharmaceuticals
Country: United Kingdom
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its revenue.
ESG Risk Rating
Industry Group (1st = lowest risk)
Pharmaceuticals 81 out of 1027
Global Universe 5017 out of 14983
What are the ESG Risk Ratings?
Notice: The information provided is for informational, non-commercial purposes only, does not constitute investment advice and is subject to conditions available in our Legal Disclaimer. Usage as a credit rating or as a benchmark is not permitted. Unless otherwise explicitly agreed in writing, usage for products and services, index creation, derivative work, portfolio or fund management, or any other usage are not permitted. By way of exception, usage is permitted only to the rated company, limited to a single reference of its own information in annual reporting and sustainability website, mentioning Sustainalytics as a source.
For corporate professionals interested in direct competitor insights
Sustainalytics' Peer Performance Insights gives an in-depth analysis of your company's ESG strengths and weaknesses compared to your competitors and industry performance. These insights can be used to identify areas of ESG improvement to help inform future management decisions that align with your organization's sustainability goals.
Our Approach to Calculating ESG Risk
The ESG Risk Ratings measure a company's exposure to industry-specific material ESG risks and how well a company is managing those risks.
Exposure refers to the extent to which a company is exposed to different material ESG issues. Our exposure score takes into consideration subindustry and company-specific factors such as its business model.
AstraZeneca PLC's Exposure is Medium
Management refers to how well a company is managing its relevant ESG issues. Our management score assesses the robustness of a company's ESG programs, practices and policies.
AstraZeneca PLC's Management of ESG Material Risk is Strong
How do the ESG Risk Ratings work?
Top Material ESG Issues for AstraZeneca PLC
Understand how exposed companies are to specific material ESG issues and how well companies are managing these issues.
Highest Controversy level that has impacted AstraZeneca PLC's ESG Risk Rating in the last three years
Highest Controversy Level